Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts

Journal of Molecular and Cellular Cardiology
E J Griffiths, A P Halestrap

Abstract

Reperfusion following a period of ischemia can salvage the myocardium only if the ischemic episode has not exceeded a certain time limit; beyond this point damage becomes irreversible. A key feature of the transition from reversible to irreversible injury is mitochondrial dysfunction which may involve the opening of a non-specific pore in the mitochondrial inner membrane. Pore opening can be induced in vitro by exposure of isolated mitochondria to high [Ca2+] and Pi. Such pore formation is sensitized by adenine nucleotide depletion and oxidative stress and can be blocked by the immunosuppressant cyclosporin A. Here we show that in isolated perfused rat hearts subjected to 30 min ischemia and 15 min reperfusion, 0.2 microM cyclosporin A restored the ATP/ADP ratio and AMP content (decreased and increased respectively during ischemia) to pre-ischemic values. In separate experiments functional recovery was assessed by monitoring the restoration of left ventricular developed pressure (LVP) during reperfusion after 30, 40 or 45 min ischemia. LVP was substantially improved in the presence of 0.2 microM cyclosporin A but did not return to pre-ischemic levels. The cyclosporin analogues G and H were less effective than cyclosporin A in p...Continue Reading

Citations

Jul 1, 1996·Molecular and Cellular Biochemistry·S M MoscaH E Cingolani
Apr 1, 1996·Journal of Bioenergetics and Biomembranes·P Bernardi, V Petronilli
Jan 7, 2011·Pediatric Cardiology·Christopher P Baines
Feb 27, 2009·Basic Research in Cardiology·Derek J HausenloyDerek M Yellon
Jan 13, 2010·Basic Research in Cardiology·Gerd HeuschRainer Schulz
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Andrea Rasola, Paolo Bernardi
Dec 16, 2006·Cardiovascular Drugs and Therapy·Henry M Honda, Peipei Ping
May 28, 2010·Cardiovascular Drugs and Therapy·Xiulan YangJames M Downey
May 23, 2007·Heart Failure Reviews·Fabio Di LisaPaolo Bernardi
Sep 17, 2005·Journal of Bioenergetics and Biomembranes·Michael Forte, Paolo Bernardi
Aug 12, 2009·Current Neurology and Neuroscience Reports·Kimmy G SuMichael Forte
Jul 17, 1995·Biochimica Et Biophysica Acta·M Zoratti, I Szabò
Feb 6, 2004·The Journal of Thoracic and Cardiovascular Surgery·Steven M WoolleyMichael S Mulligan
Aug 8, 1997·Clinica Chimica Acta; International Journal of Clinical Chemistry·L T McGrathJ H Brown
Sep 12, 2000·European Journal of Pharmacology·F RuizJ Satrústegui
Feb 5, 2003·Experimental Cell Research·Sergey Ya ProskuryakovVladimir L Gabai
Apr 12, 2003·Journal of Molecular and Cellular Cardiology·Derek J Hausenloy, Derek M Yellon
Sep 29, 2000·Pharmacology & Therapeutics·J Spychala
Apr 24, 2001·Pharmacology & Therapeutics·M S SuleimanE J Griffiths
Sep 8, 1998·International Journal of Immunopharmacology·H Farghali, K Masek
Oct 13, 2000·Journal of the American College of Surgeons·T N RobinsonA H Harken
Jun 5, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Koji WakimotoIssei Komuro
Jun 23, 1999·The Biochemical Journal·V DoyleM Crompton
Jul 16, 2003·Journal of Gastroenterology and Hepatology·Narci C Teoh, Geoffrey C Farrell
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Valentina GiorgioPaolo Bernardi
Aug 24, 2011·The Journal of Biological Chemistry·Paavo KorgeJames N Weiss
Sep 21, 2011·The Journal of Biological Chemistry·Tiffany T NguyenElizabeth Murphy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.